News
WALTHAM, MA—August 10, 2021 — CorEvitas, LLC, the leading sponsor of registries in autoimmune and inflammatory diseases announces first patient enrollment in a new biospecimen study for patients enrolled in its rheumatology registries. Eligible rheumatology registry patients will contribute...Learn More
News
Insights advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans Waltham, MA, September 21, 2021 —CorEvitas, LLC, the gold-standard leader in longitudinal real-world data in autoimmune and inflammatory diseases...Learn More
News
Waltham, MA and London, UK, August 3, 2021 —CorEvitas, LLC welcomes Amrit Ray, MD, MBA, to its Board of Directors. CorEvitas [kohr-eh'-vi-tahs] is the built-for-purpose provider of gold-standard real-world evidence, striving to advance patient care by generating high quality curated data on newly...Learn More
News
Retina specialty data provider combines with leader in real-world evidence Waltham, MA, USA, London, UK, and Naperville, IL, USA, July 22, 2021—CorEvitas, LLC is pleased to share the addition of Vestrum Health to its organization. Vestrum Health, the first-to-market leader in data analytics of...Learn More